2022 Q1 Form 10-Q Financial Statement

#000121390022026590 Filed on May 16, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q1
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $2.463M $2.790M
YoY Change -11.73% 125.0%
% of Gross Profit
Research & Development $596.3K $2.050M
YoY Change -70.91% 93.4%
% of Gross Profit
Depreciation & Amortization $2.070K $0.00
YoY Change
% of Gross Profit
Operating Expenses $3.059M $4.840M
YoY Change -36.8% 110.43%
Operating Profit -$3.059M
YoY Change
Interest Expense $5.120K $0.00
YoY Change -100.0%
% of Operating Profit
Other Income/Expense, Net $146.0K $10.00K
YoY Change 1360.0%
Pretax Income -$2.908M -$4.830M
YoY Change -39.8% 111.84%
Income Tax
% Of Pretax Income
Net Earnings -$2.908M -$4.834M
YoY Change -39.84% 112.01%
Net Earnings / Revenue
Basic Earnings Per Share -$0.13
Diluted Earnings Per Share -$125.6K -$303.6K
COMMON SHARES
Basic Shares Outstanding 23.15M shares
Diluted Shares Outstanding 23.15M shares

Balance Sheet

Concept 2022 Q1 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $12.69M $5.640M
YoY Change 124.99% 13.94%
Cash & Equivalents $12.69M $5.640M
Short-Term Investments
Other Short-Term Assets $275.8K $530.0K
YoY Change -47.96% -45.92%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $12.96M $6.170M
YoY Change 110.13% 3.87%
LONG-TERM ASSETS
Property, Plant & Equipment $289.8K $310.0K
YoY Change -6.52%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $998.7K $2.460M
YoY Change -59.4%
TOTAL ASSETS
Total Short-Term Assets $12.96M $6.170M
Total Long-Term Assets $998.7K $2.460M
Total Assets $13.96M $8.630M
YoY Change 61.8% 45.29%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $415.1K $640.0K
YoY Change -35.14% 220.0%
Accrued Expenses $1.746M $1.380M
YoY Change 26.53% 626.32%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $30.00K
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.171M $2.040M
YoY Change 6.43% 423.08%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.062M $970.0K
YoY Change 9.46%
Total Long-Term Liabilities $1.062M $970.0K
YoY Change 9.46%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.171M $2.040M
Total Long-Term Liabilities $1.062M $970.0K
Total Liabilities $3.256M $3.010M
YoY Change 8.18% 671.79%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $10.71M $5.618M
YoY Change
Total Liabilities & Shareholders Equity $13.96M $8.630M
YoY Change 61.8% 45.29%

Cashflow Statement

Concept 2022 Q1 2021 Q1
OPERATING ACTIVITIES
Net Income -$2.908M -$4.834M
YoY Change -39.84% 112.01%
Depreciation, Depletion And Amortization $2.070K $0.00
YoY Change
Cash From Operating Activities -$2.497M -$2.840M
YoY Change -12.09% 55.19%
INVESTING ACTIVITIES
Capital Expenditures -$30.00K
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $30.00K
YoY Change -100.0%
Cash From Investing Activities $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 9.124M 4.080M
YoY Change 123.62%
NET CHANGE
Cash From Operating Activities -2.497M -2.840M
Cash From Investing Activities 0.000
Cash From Financing Activities 9.124M 4.080M
Net Change In Cash $0.00 1.240M
YoY Change -100.0% -167.76%
FREE CASH FLOW
Cash From Operating Activities -$2.497M -$2.840M
Capital Expenditures -$30.00K
Free Cash Flow -$2.497M -$2.810M
YoY Change -11.15%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001513525
CY2022Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
USD
CY2022Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
USD
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
USD
CY2022Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
USD
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
USD
CY2022Q1 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
USD
CY2022Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
USD
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
USD
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
USD
CY2022Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
USD
CY2021Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
USD
CY2022Q1 adil Reclassification Of Stockbased Comp From Accrued Expenses
ReclassificationOfStockbasedCompFromAccruedExpenses
USD
CY2022Q1 adil Noncash Cost Of Commitment Shares
NoncashCostOfCommitmentShares
USD
CY2021Q1 adil Unvested Restricted Stock Awards
UnvestedRestrictedStockAwards
shares
CY2022Q1 adil Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included I Additions
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedIAdditions
USD
CY2021Q4 adil Manufacturing Expenses
ManufacturingExpenses
USD
CY2021Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
USD
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Payments
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments
USD
CY2022Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
USD
CY2021Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
USD

Files In Submission

Name View Source Status
0001213900-22-026590-index-headers.html Edgar Link pending
0001213900-22-026590-index.html Edgar Link pending
0001213900-22-026590.txt Edgar Link pending
0001213900-22-026590-xbrl.zip Edgar Link pending
adil-20220331.xsd Edgar Link pending
adil-20220331_cal.xml Edgar Link unprocessable
adil-20220331_def.xml Edgar Link unprocessable
adil-20220331_lab.xml Edgar Link unprocessable
adil-20220331_pre.xml Edgar Link unprocessable
f10q0322ex31-1_adialpharm.htm Edgar Link pending
f10q0322ex31-2_adialpharm.htm Edgar Link pending
f10q0322ex32-1_adialpharm.htm Edgar Link pending
f10q0322ex32-2_adialpharm.htm Edgar Link pending
f10q0322_adialpharm.htm Edgar Link pending
f10q0322_adialpharm_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending